Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis [0.03%]
阿布昔替尼、巴瑞克替尼和乌帕替尼治疗特应性皮炎真实世界有效性和安全性的系统评价和 meta 分析
Amalie Thorsti Møller Rønnstad,Daniel Isufi,Christopher G Bunick et al.
Amalie Thorsti Møller Rønnstad et al.
Background: Oral Janus kinase inhibitors (JAKi) have proven effective in the treatment of atopic dermatitis (AD) in multiple clinical trials, providing rapid response, deep efficacy when given at the highest formulated do...
Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma [0.03%]
高危皮肤鳞状细胞癌的围手术期系统治疗
Kelly M Kimball,Rachel E Politi,Kathryn T Shahwan
Kelly M Kimball
The incidence of cutaneous squamous cell carcinoma (CSCC) is on the rise. While the majority of cases are curable with surgery alone, the burden of high-risk tumors that require additional therapies is increasing. While systemic therapy has...
Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials [0.03%]
Dupixent治疗成人结节性痒疹患者的有效性和安全性：两项随机III期临床试验的亚组分析
Brian S Kim,Margarida Gonçalo,Tsukasa Ugajin et al.
Brian S Kim et al.
Background: Prurigo nodularis (PN) is a chronic inflammatory skin condition characterized by intensely pruritic papulonodular lesions. Patients with PN frequently experience comorbid atopic conditions. Dupilumab is the fi...
Correction to: Summary of Research: Efficacy and Safety of Delgocitinib Cream in Adults with Moderate to Severe Chronic Hand Eczema (DELTA 1 and DELTA 2): Results from Multicentre, Randomised, Controlled, Double‑Blind, Phase 3 Trials [0.03%]
德 gle 茶因乳膏治疗中至重度慢性手部湿疹有效性和安全性的汇总分析：DELTA 1 和 DELTA 2 多中心、随机、对照、双盲 III 期试验结果的更正
Robert Bissonnette,Fatima Albreiki,Benjamin D Ehst et al.
Robert Bissonnette et al.
Published Erratum
American journal of clinical dermatology. 2025 Nov 1. DOI:10.1007/s40257-025-00989-x 2025
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks [0.03%]
克立宾特泡沫剂治疗脂溢性皮炎长期疗效及安全性的开放性II期临床试验：为期一年的试验结果
Andrew F Alexis,Michael Bukhalo,Fran E Cook-Bolden et al.
Andrew F Alexis et al.
Background: The efficacy and safety of once-daily roflumilast foam 0.3%, a potent phosphodiesterase 4 inhibitor, has been demonstrated in patients with seborrheic dermatitis (SD). ...
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review [0.03%]
寻常痤疮对健康相关生活质量及心理社会领域的影响：系统评价
Alison M Layton,Vincenzo Bettoli,Valentine Delore et al.
Alison M Layton et al.
Background: Acne vulgaris (acne) is a common dermatological condition that can profoundly affect psychosocial well-being. Health-related quality of life (HRQoL) is an important outcome measure to assess the burden of acne...
Dupilumab and Cutaneous T-Cell Lymphoma: A Call for Vigilance, Not Alarm [0.03%]
杜普利尤单抗与皮肤T细胞淋巴瘤：警惕而非警报
Tiago Torres
Tiago Torres
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials [0.03%]
特纳利珠单抗治疗中重度特应性皮炎成人患者的疗效和安全性：来自III期试验的事后分析
Tiffany Mayo,Jonathan I Silverberg,April Armstrong et al.
Tiffany Mayo et al.
Background: Differences in atopic dermatitis (AD) prevalence, clinical presentation, and pathophysiology have been reported in different ethnic/racial groups; however, clinical trial data for patients with skin of color a...
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations [0.03%]
口服米诺地尔治疗斑秃：风险、获益及建议
Michael M Ong,Yingjoy Li,Shari R Lipner
Michael M Ong
Low-dose oral minoxidil has gained recognition as an off-label treatment for hair loss disorders, including androgenetic alopecia, telogen effluvium, and alopecia areata. Originally developed to treat hypertension, its hair growth-promoting...
Rahaf Zyad Attar,Alice B Gottlieb,Sibel Zehra Aydin
Rahaf Zyad Attar
Enthesitis represents a hallmark feature and central pathological process in psoriatic arthritis and has been proposed as a potential early indicator in patients with psoriasis prior to the onset of clinically apparent psoriatic arthritis. ...